The strength in AUD and NZD overnight has helped my EURNZD SHORT position from last week (January 11) reach target 2 today for a total net gain of 210 pips. On Wednesday I wrote “The longer term Weekly and Monthly charts are in strong downtrends, so this is position very much with the trend. The entry point at 1.5070 was a confluence of the 38.2 Fibonacci level that did not break yesterday, the 20 DMA that was breeched this morning and the 50 DMA zone. The Parabolic SAR has remained negative since January 3, the RSI is 47 and falling and the MACD remains weak. Target 1 also coincides with the 14 DATR and the 23.6 Fibonacci level at 1.4948. Target 2 is below the lower daily Bollinger band and sits with the Weekly lower Bollinger band at 1.4860.”
https://analysis.hotforex.com/ has had a good start to 2017 with all four January trades achieving both Target 1 and Target 2 for a total net gain of 904 pips.
Click here to access the HotForex Economic calendar.
Want to learn to trade and analyse the markets? Join our webinars and get analysis and trading ideas combined with better understanding on how markets work.
Click HERE to register the next webinar will start in:
Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in FX and CFDs products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.